ANTI-DESTRUCTIVE EFFECT OF RITUXIMAB AND B-CELL COUNT IN RHEUMATOID ARTHRITIS PATIENTS

被引：0
|
作者：
Pivanova, Anastasia V. [1 ]
Lukina, Galina V. [1 ]
Sigidin, Yakov A. [1 ]
Smirnov, Aleksandr V. [1 ]
Kuzikyants, Kristina Kh [1 ]
Kuznetsova, Anna Yu [1 ]
Nasonov, Evgeni L. [1 ]
机构：
[1] VA Nasonova Res Inst Rheumatol, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2016-211055.50
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
08.50
引用
收藏
页码：A97 / A97
页数：1
相关论文
共 50 条
  • [1] RITUXIMAB: COMPARISON CLINICAL AND ANTI-DESTRUCTIVE EFFECTS AND B-CELL COUNT IN RHEUMATOID ARTHRITIS PATIENTS
    Pivanova, A.
    Lukina, G.
    Sigidin, Y.
    Smirnov, A.
    Glukhova, S.
    Kuznetsova, A.
    Kuzikyants, K.
    Nasonov, E.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (01) : S78 - S78
  • [2] CORRELATION BETWEEN CLINICAL AND ANTI-DESTRUCTIVE EFFECTS OF RITUXIMAB (RTM) AND B-CELLS COUNT IN RHEUMATOID ARTHRITIS (RA) PATIENTS
    Pivanova, A. V.
    Lukina, G.
    Sigidin, Y.
    Smirnov, A. V.
    Kuzikyants, K. Kh.
    Kuznetsova, A. Yu.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1017 - 1017
  • [3] Repeated B-cell depletion with rituximab in rheumatoid arthritis
    Edwards, J
    Leandro, M
    [J]. ARTHRITIS RESEARCH & THERAPY, 2003, 5 (Suppl 3) : S42 - S42
  • [4] Repeated B-cell depletion with rituximab in rheumatoid arthritis
    J Edwards
    M Leandro
    [J]. Arthritis Res Ther, 5
  • [5] THE INFLUENCE OF RITUXIMAB AND TOCILIZUMAB TREATMENT ON B-CELL SUBSETS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Suponitskaya, E.
    Aleksankin, A.
    Avdeeva, A.
    Aleksandrova, E.
    Novikov, A.
    Nasonov, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 498 - 498
  • [6] Response to Rituximab and Timeframe to Relapse in Rheumatoid Arthritis Patients Association with B-Cell Markers
    Pyrpasopoulou, Athina
    Douma, Stella
    Triantafyllou, Areti
    Simoulidou, Elisavet
    Samara, Magda
    Parapanisiou, Efthymia
    Aslanidis, Spyros
    [J]. MOLECULAR DIAGNOSIS & THERAPY, 2010, 14 (01) : 43 - 48
  • [7] Rituximab: novel B-cell depletion therapy for the treatment of rheumatoid arthritis
    Dass, Shouvik
    Vital, Edward M.
    Emery, Paul
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (18) : 2559 - 2570
  • [8] The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment
    Cambridge, G.
    Perry, H. C.
    Nogueira, L.
    Serre, G.
    Parsons, H. M.
    De La Torre, I.
    Dickson, M. C.
    Leandro, M. J.
    Edwards, J. C. W.
    [J]. JOURNAL OF AUTOIMMUNITY, 2014, 50 : 67 - 76
  • [9] Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response
    Breedveld, Ferdinand
    Agarwal, Sunil
    Yin, Ming
    Ren, Song
    Li, Nicole F.
    Shaw, Tim M.
    Davies, Brian E.
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (09): : 1119 - 1128
  • [10] EFFECT OF SULFASALAZINE ON B-CELL HYPERACTIVITY IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    IMAI, F
    SUZUKI, T
    ISHIBASHI, T
    TANAKA, M
    AKIYAMA, Y
    DOHI, Y
    [J]. JOURNAL OF RHEUMATOLOGY, 1994, 21 (04) : 612 - 615
12345